Cargando…
Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review
With the Food and Drug Administration designation in 2017 of 3,4-methylenedioxymethamphetamine (MDMA) as a breakthrough therapy in post-traumatic stress disorder and psilocybin in treatment-resistant depression, psychedelic drugs have continued to garner the attention of researchers and clinicians f...
Autores principales: | Fonseka, Lakshan N, Woo, Benjamin KP |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251361/ https://www.ncbi.nlm.nih.gov/pubmed/37303932 http://dx.doi.org/10.5498/wjp.v13.i5.182 |
Ejemplares similares
-
Social media and schizophrenia: An update on clinical applications
por: Fonseka, Lakshan N, et al.
Publicado: (2022) -
3,4-methylenedioxymethamphetamine (MDMA): current perspectives
por: Meyer, Jerrold S
Publicado: (2013) -
3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
por: Young, M B, et al.
Publicado: (2015) -
Effects of 3,4-Methylenedioxymethamphetamine Administration on Retinal Physiology in the Rat
por: Martins, João, et al.
Publicado: (2011) -
Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms
por: McCann, Una D., et al.
Publicado: (2007)